Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
17.6M
-
Shares change
-
+3.9M
-
Total reported value, excl. options
-
$199M
-
Value change
-
+$44.4M
-
Put/Call ratio
-
0.51
-
Number of buys
-
34
-
Number of sells
-
-31
-
Price
-
$11.30
Significant Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q1 2022
96 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q1 2022.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.6M shares
of 120M outstanding shares and own 14.63% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (2.71M shares), Omega Fund Management, LLC (1.79M shares), BlackRock Inc. (1.31M shares), COWEN AND COMPANY, LLC (1.26M shares), Parkman Healthcare Partners LLC (1.09M shares), VANGUARD GROUP INC (957K shares), COMMODORE CAPITAL LP (893K shares), Point72 Asset Management, L.P. (725K shares), Artal Group S.A. (700K shares), and PURA VIDA INVESTMENTS, LLC (683K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.